Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'cancer'  -  Page 5
Latest

Tri-county hospitals oppose Trump health care bill

By   /  Friday, March 24th, 2017  /  Central Coast Health Watch, Latest news, Technology, Tri-County Economy  /  Comments Off on Tri-county hospitals oppose Trump health care bill

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Gene technology raises ethical questions

By   /  Friday, March 10th, 2017  /  Central Coast Health Watch, Latest news, Op/Eds, Opinion  /  Comments Off on Gene technology raises ethical questions

By Frank Kalman A relatively obscure talk about genes was given at UC Santa Barbara recently by Dr. Siddhartha Mukherjee, a researcher and clinical oncologist at Columbia University and author of a Pulitzer Prize winning book, the “Emperor of all Maladies: A Biography of Cancer.” It was, however, on par in terms of gravity with Read More →

Read More →
Latest

Agilent cancer treatment approved in Europe

By   /  Thursday, February 2nd, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Agilent cancer treatment approved in Europe

Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →

Read More →
Latest

Patent ruling in favor of Amgen has shares skyrocketing

By   /  Friday, January 13th, 2017  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Patent ruling in favor of Amgen has shares skyrocketing

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Elings donates $4 million to Cancer Center of Santa Barbara

By   /  Friday, January 6th, 2017  /  Central Coast Health Watch, Latest news  /  Comments Off on Elings donates $4 million to Cancer Center of Santa Barbara

Philanthropist Virgil Elings donated $4 million to the new Cancer Center of Santa Barbara to open in the fall at 540 W. Pueblo St. The $53 million cancer center, which merged with Sansum Clinic in 2012, will be renamed the Ridley-Tree Cancer Center to honor Lady Leslie Ridley-Tree’s $10.73 million donation. The Elings Oncology Building Read More →

Read More →
Latest

Amgen buying rights to Advaxis cancer treatment

By   /  Tuesday, August 2nd, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen buying rights to Advaxis cancer treatment

Thousand Oaks-based biotech giant Amgen said it will buy the rights to develop and commercialize a cancer immunotherapy treatment Aug. 2. Under the agreement, Amgen will pay Princeton, N.J.-based Advaxis $40 million and buy $25 million worth of Advaxis common stock for the rights to develop and commercialize a preclinical cancer immunotherapy, which is designed Read More →

Read More →
Latest

Study shows Amgen’s new biosimilar cancer drug safe, effective

By   /  Wednesday, September 23rd, 2015  /  Latest news, Technology, Top Stories  /  Comments Off on Study shows Amgen’s new biosimilar cancer drug safe, effective

Pharmaceuticals Amgen and Allergan announced positive Phase 3 study results of their new drug ABP 215 on Sept. 23. The drug, used to treat lung cancer, is being developed as a biosimilar to Roche Holding AG’s Avastin. ABP 215 showed clinical safety and effectiveness compared to Avastin. “Lung cancer is the leading cause of cancer Read More →

Read More →